Caspofungin: a review of its use in the treatment of fungal infections (Q36257157)

13 August 2017

1 reference

title

Caspofungin: a review of its use in the treatment of fungal infections (English)

1 reference

13 August 2017

2

Caroline M Perry

1 reference

13 August 2017

Paul L McCormack

1

1 reference

PubMed ID

16162025

13 August 2017

language of work or name

1 reference

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

65

1 reference

13 August 2017

14

1 reference

13 August 2017

2049-2068

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200565140-00009

13 August 2017

0 references

cites work

Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species

1 reference

12 December 2020

Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia

1 reference

12 December 2020

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

12 December 2020

Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice

1 reference

12 December 2020

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

1 reference

12 December 2020

British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections

1 reference

12 December 2020

Glucan synthase inhibitors as antifungal agents

1 reference

12 December 2020

Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

1 reference

12 December 2020

Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections

1 reference

12 December 2020

Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates.

1 reference

12 December 2020

A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis

1 reference

12 December 2020

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

1 reference

12 December 2020

Studies of the paradoxical effect of caspofungin at high drug concentrations

1 reference

12 December 2020

Prophylaxis and treatment of fungal infections in oncohematological patients

1 reference

12 December 2020

Treatment of murine disseminated candidiasis with L-743,872

1 reference

12 December 2020

Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole

1 reference

12 December 2020

Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study

1 reference

12 December 2020

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

1 reference

12 December 2020

A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis

1 reference

12 December 2020

New and emerging antifungal agents: impact on respiratory infections

1 reference

12 December 2020

Practice guidelines for the treatment of fungal infections. For the Mycoses Study Group. Infectious Diseases Society of America

1 reference

12 December 2020

Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A.

1 reference

12 December 2020

Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections

1 reference

12 December 2020

Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection.

1 reference

12 December 2020

The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro

1 reference

12 December 2020

Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America

1 reference

12 December 2020

Caspofungin uptake is mediated by a high-affinity transporter in Candida albicans

1 reference

12 December 2020

Emerging fungal resistance

1 reference

12 December 2020

Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate

1 reference

12 December 2020

Treatment of fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

1 reference

12 December 2020

In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species

1 reference

12 December 2020

In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates

1 reference

12 December 2020

Echinocandin antifungal drugs

1 reference

12 December 2020

Hepatic uptake of the novel antifungal agent caspofungin

1 reference

12 December 2020

Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity

1 reference

12 December 2020

Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans

1 reference

12 December 2020

Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.

1 reference

12 December 2020

In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species

1 reference

12 December 2020

Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths

1 reference

12 December 2020

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

12 December 2020

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

1 reference

12 December 2020

Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis

1 reference

12 December 2020

Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis

1 reference

12 December 2020

Invasive aspergillosis

1 reference

12 December 2020

Guidelines for treatment of candidiasis

1 reference

12 December 2020

Potential for interactions between caspofungin and nelfinavir or rifampin

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.

1 reference

12 December 2020

Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice

1 reference

12 December 2020

Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations

1 reference

12 December 2020

1 reference

12 December 2020

A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans

1 reference

12 December 2020

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

1 reference

12 December 2020

Newer systemic antifungal agents : pharmacokinetics, safety and efficacy

1 reference

12 December 2020

Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma

1 reference

12 December 2020

Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp.

1 reference

12 December 2020

Caspofungin: an echinocandin antifungal agent

1 reference

12 December 2020

Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases

1 reference

12 December 2020

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

12 December 2020

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

1 reference

12 December 2020

New antifungal drugs and new clinical trials: interpreting results may be difficult

1 reference

12 December 2020

Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections.

1 reference

12 December 2020

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

1 reference

12 December 2020

The Candida albicans Cdr2p ATP-binding cassette (ABC) transporter confers resistance to caspofungin.

1 reference

12 December 2020

Treatment of murine Candida krusei or Candida glabrata infection with L-743,872

1 reference

12 December 2020

Antifungal resistance among Candida species

1 reference

12 December 2020

Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

1 reference

12 December 2020

In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods

1 reference

12 December 2020

Caspofungin activity against clinical isolates of fluconazole-resistant Candida

1 reference

12 December 2020

Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi

1 reference

12 December 2020

Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase

1 reference

12 December 2020

Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).

1 reference

12 December 2020

10.2165/00003495-200565140-00009

Identifiers

DOI

1 reference

PubMed ID

16162025

Dimensions Publication ID

13 August 2017

0 references

1 reference

PubMed ID

16162025